levetiracetam orpha 500 mg compresse rivestite con film
acino pharma ag - levetiracetamum - compresse rivestite con film - levetiracetamum 500 mg, arom.: vanillinum, colore.: e 104, conserv.: e 200, excipiens pro compresso haze. - antiepileptikum - synthetika
levetiracetam orpha 1000 mg compresse rivestite con film
acino pharma ag - levetiracetamum - compresse rivestite con film - levetiracetamum 1000 mg, excipiens pro compresso haze. - antiepileptikum - synthetika
adasuve 9.1 mg einzeldosiertes polvere per inalazione
orpha swiss gmbh - loxapinum - einzeldosiertes polvere per inalazione - loxapinum 9.1 mg polvere per dosi. - antipsicotico - synthetika
doptelet
swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenia - antiemorragici - doptelet è indicato per il trattamento della trombocitopenia grave, in pazienti adulti con malattia cronica di fegato che sono in programma di sottoporsi a una procedura invasiva. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. corticosteroidi, immunoglobuline).
gamifant
swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - emoglobinuria, parossistica - immunosoppressori - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
rapibloc 300 mg polvere per soluzione per infusione
orpha swiss gmbh - landiololum - polvere per soluzione per infusione - landiololi hydrochloridum 300 mg corresp. landiololum 280 mg, mannitolum, natrii hydroxidum corresp. natrium max. 4.6 mg, pro vitro. - hoch selektiver beta-1-adrenorezeptor-antagonist - synthetika
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - inversione del blocco neuromuscolare indotto da rocuronio o vecuronio. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
nalbuphin orpha injektionslösung
nalbuphin orpha solution injectable